Cargando…

The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes

In this paper, we assess the cost-effectiveness of 1 g daily of carnosine (an over the counter supplement) in addition to standard care for the management of type 2 diabetes and compare it to standard care alone. Dynamic multistate life table models were constructed in order to estimate both clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menon, Kirthi, de Courten, Barbora, Magliano, Dianna J., Ademi, Zanfina, Liew, Danny, Zomer, Ella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747040/ https://www.ncbi.nlm.nih.gov/pubmed/35011089 http://dx.doi.org/10.3390/nu14010215

Ejemplares similares

Estimating the benefits of obesity prevention on productivity: an Australian perspective
por: Menon, Kirthi, et al.
Publicado: (2022)

Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling
por: Uli, Regina E, et al.
Publicado: (2020)

Assessing the impact of smoking on the health and productivity of the working-age Indonesian population using modelling
por: Satyana, Regina P U, et al.
Publicado: (2020)

Effects of supplementation with carnosine and other histidine-containing dipeptides on chronic disease risk factors and outcomes: protocol for a systematic review of randomised controlled trials
por: Menon, Kirthi, et al.
Publicado: (2018)

The impact of diabetes on the productivity and economy of Bangladesh
por: Afroz, Afsana, et al.
Publicado: (2020)

Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
por: Morton, Jedidiah I., et al.
Publicado: (2022)

Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden
por: Ademi, Zanfina, et al.
Publicado: (2021)

Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial
por: Saadati, Saeede, et al.
Publicado: (2023)

Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial
por: Menon, Kirthi, et al.
Publicado: (2021)

Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
por: Abushanab, Dina, et al.
Publicado: (2023)

Diabetes Prevention and Treatment Strategies: Are we doing enough?
por: Backholer, Kathryn, et al.
Publicado: (2013)

The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
por: Zomer, Ella, et al.
Publicado: (2012)

Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes
por: Lloyd, Melanie, et al.
Publicado: (2023)

Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
por: Ademi, Zanfina, et al.
Publicado: (2016)

Nutritional Interventions for COVID-19: A Role for Carnosine?
por: Feehan, Jack, et al.
Publicado: (2021)

Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Shared Medical Appointments May Be Effective for Improving Clinical and Behavioral Outcomes in Type 2 Diabetes: A Narrative Review
por: Menon, Kirthi, et al.
Publicado: (2017)

Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia
por: Hastings, Kaitlyn, et al.
Publicado: (2022)

Author Correction: Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2020)

Anti-Cancer Effects of Carnosine—A Dipeptide Molecule
por: Prakash, Monica D., et al.
Publicado: (2021)

Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis
por: Pease, Anthony, et al.
Publicado: (2020)

Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
por: Baye, Estifanos, et al.
Publicado: (2018)

Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans
por: de Courten, Barbora, et al.
Publicado: (2015)

Burden of disease and productivity impact of Streptococcus suis infection in Thailand
por: Rayanakorn, Ajaree, et al.
Publicado: (2021)

Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes
por: Chin, Ken Lee, et al.
Publicado: (2019)

The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence
por: Schön, Martin, et al.
Publicado: (2019)

Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-analysis
por: Ofori-Asenso, Richard, et al.
Publicado: (2019)

A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect
por: Regazzoni, Luca, et al.
Publicado: (2016)

Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation
por: Ademi, Zanfina, et al.
Publicado: (2022)

Exploring the Health and Economic Burden Among Truck Drivers in Australia: A Health Economic Modelling Study
por: Lee, Peter, et al.
Publicado: (2022)

Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial
por: de Courten, Barbora, et al.
Publicado: (2015)

Improved spectral resolution and high reliability of in vivo (1)H MRS at 7 T allow the characterization of the effect of acute exercise on carnosine in skeletal muscle
por: Just Kukurová, Ivica, et al.
Publicado: (2015)

Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review
por: Docking, Sean, et al.
Publicado: (2023)

Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden study
por: Lee, Peter, et al.
Publicado: (2022)

Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy
por: Bailey, Cate, et al.
Publicado: (2020)

Cost of gastroenteritis in Australia: A healthcare perspective
por: Barker, S. Fiona, et al.
Publicado: (2018)

Treatment costs for patients with Streptococcus suis infection in Northern Thailand: a hospital-based observational study of 14-year data
por: Rayanakorn, Ajaree, et al.
Publicado: (2023)

Effect of muscle fibre types and carnosine levels on the expression of carnosine-related genes in pig skeletal muscle
por: Kalbe, Claudia, et al.
Publicado: (2023)

Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4
por: Masuoka, Nobutaka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f7far4tdjj63bs1vbaeffjj4q2